290 related articles for article (PubMed ID: 24575143)
1. Cell-mediated immune responses in paraneoplastic neurological syndromes.
Zaborowski MP; Michalak S
Clin Dev Immunol; 2013; 2013():630602. PubMed ID: 24575143
[TBL] [Abstract][Full Text] [Related]
2. [Paraneoplastic neurological syndrome and autoantibodies].
Hayashi Y; Inuzuka T
Brain Nerve; 2013 Apr; 65(4):385-93. PubMed ID: 23568986
[TBL] [Abstract][Full Text] [Related]
3. Improved Prognosis and Increased Tumor-Infiltrating Lymphocytes in Patients Who Have SCLC With Neurologic Paraneoplastic Syndromes.
Iams WT; Shiuan E; Meador CB; Roth M; Bordeaux J; Vaupel C; Boyd KL; Summitt IB; Wang LL; Schneider JT; Warner JL; Zhao Z; Lovly CM
J Thorac Oncol; 2019 Nov; 14(11):1970-1981. PubMed ID: 31201935
[TBL] [Abstract][Full Text] [Related]
4. [Neurological syndromes, encephalitis].
Yamamoto T; Tsuji S
Gan To Kagaku Ryoho; 2010 Jun; 37(6):995-1005. PubMed ID: 20567100
[TBL] [Abstract][Full Text] [Related]
5. Granzyme B in peripheral blood mononuclear cells as a measure of cell-mediated immune response in paraneoplastic neurological syndromes and malignancy.
Zaborowski MP; Stefens-Stawna P; Osztynowicz K; Piorunek T; Batura-Gabryel H; Dyzmann-Sroka A; Kozubski W; Nowak-Markwitz E; Michalak S
Cancer Immunol Immunother; 2021 May; 70(5):1277-1289. PubMed ID: 33136178
[TBL] [Abstract][Full Text] [Related]
6. Imbalances in circulating lymphocyte subsets in Hu antibody associated paraneoplastic neurological syndromes.
de Beukelaar JW; Sillevis Smitt PA; Hop WC; Kraan J; Hooijkaas H; Verjans GM; Gratama JW
Eur J Neurol; 2007 Dec; 14(12):1383-91. PubMed ID: 18028190
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal synthesis of onconeural antibodies in patients with paraneoplastic syndromes.
Corsini E; Gaviani P; Chiapparini L; Lazzaroni M; Ciusani E; Bisogno R; Silvani A; Salmaggi A; Bernardi G
J Neuroimmunol; 2016 Jan; 290():119-22. PubMed ID: 26711581
[TBL] [Abstract][Full Text] [Related]
8. A single center retrospective study of paraneoplastic neurological syndromes with positive onconeural antibodies.
Fu P; He L; Tang N; Nie Q; Li Z
J Clin Neurosci; 2021 Jul; 89():336-342. PubMed ID: 34119290
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
[TBL] [Abstract][Full Text] [Related]
10. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
[TBL] [Abstract][Full Text] [Related]
11. [Pathogenesis of paraneoplastic neurological syndromes].
Tanaka K
Brain Nerve; 2010 Apr; 62(4):309-18. PubMed ID: 20420170
[TBL] [Abstract][Full Text] [Related]
12. Imbalance in circulating T lymphocyte subsets contributes to Hu antibody-associated paraneoplastic neurological syndromes.
Zhang L; Qian W; Chen Q; Yin L; Li B; Wang H
Cell Immunol; 2014 Aug; 290(2):245-50. PubMed ID: 25173445
[TBL] [Abstract][Full Text] [Related]
13. [Onconeural antibodies as a tool for diagnosis of malignant tumors and paraneoplastic neurological disorders].
Belousov PV; Shebzukhov IuV; Nedospasov SA; Kuprash DV
Mol Gen Mikrobiol Virusol; 2007; (2):6-13. PubMed ID: 17598451
[TBL] [Abstract][Full Text] [Related]
14. [Paraneoplastic neurological syndromes in 2008].
Honnorat J
Rev Neurol (Paris); 2009 May; 165 Suppl 3():S59-65. PubMed ID: 19524096
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic neurological syndromes in lung cancer patients with or without onconeural antibodies.
Raspotnig M; Vedeler C; Storstein A
J Neurol Sci; 2015 Jan; 348(1-2):41-5. PubMed ID: 25467140
[TBL] [Abstract][Full Text] [Related]
16. [Paraneoplastic neurological syndromes and autoimmune encephalitis].
Stich O; Rauer S
Nervenarzt; 2014 Apr; 85(4):485-98; quiz 499-501. PubMed ID: 24668402
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic neurological syndromes and onconeural antibodies: clinical and immunological aspects.
Storstein A; Vedeler CA
Adv Clin Chem; 2007; 44():143-85. PubMed ID: 17682342
[TBL] [Abstract][Full Text] [Related]
18. Onconeural versus paraneoplastic antigens?
Eichmüller SB; Bazhin AV
Curr Med Chem; 2007; 14(23):2489-94. PubMed ID: 17979702
[TBL] [Abstract][Full Text] [Related]
19. Onconeural antibodies are essential to diagnose paraneoplastic neurological syndromes.
Honnorat J
Acta Neurol Scand Suppl; 2006; 183():64-8. PubMed ID: 16637934
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotypical characterization of paraneoplastic neurological syndrome patients: a multicentric study.
Lorusso L; Precone V; Hart IK; Giometto B; Pezzani R; Ngonga GK; Ngonga GKNK; Paolacci S; Ferrari D; Ricevuti G; Marshall E; Bertelli M
J Biosci; 2021; 46():. PubMed ID: 33709965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
